Clarithromycin
Product Images NDC 68071-2869

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 68071-2869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2869 2)

Pdp (68071 2869 2)
Clarithromycin 500 mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates a package of 20 oval-shaped white tablets debossed with 'GG C9' on one side. It includes NDC 68071-2869-2 and notes the product is Rx only, manufactured by S.C. Sandoz S.R.L. Romania. Storage instructions specify controlled temperature between 68-77°F with a warning to keep out of reach of children.*
FDA Label Image

Clarithrofigure2 (Clarithromycinfigure2)

Clarithrofigure2 (Clarithromycinfigure2)
A line graph displaying the mean plasma concentration (mcg/mL) of Clarithromycin over time after dosing (hours). The chart compares Clarithromycin extended-release (2 x 500 mg every 24 hours) versus Clarithromycin immediate release (500 mg every 12 hours), showing their respective plasma concentration profiles during a 24-hour period.*
FDA Label Image

Chemicalstructure (Clarithromycin)

Chemicalstructure (Clarithromycin)
Chemical structure diagram of clarithromycin showing its molecular arrangement, including multiple ring structures and functional groups consistent with a macrolide antibiotic.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A survival curve line graph comparing the proportion surviving over time between Clarithromycin and placebo groups. The x-axis represents days since randomization up to approximately 700 days, and the y-axis shows the proportion surviving from 0 to 1. The graph includes two lines: a solid line for Clarithromycin and a dotted line for placebo, with the Clarithromycin group showing a higher survival proportion throughout the timeline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.